What is the EDIT stock price prediction for next 2 weeks?

According to our price prediction algorithm,Editas Medicine, Inc. (EDIT) price will be around $3.26 in the next 2 weeks. This means it will increase by 8.806666666666674 from the last closing price. This prediction may vary from other time period filters for EDIT stock.

What can be the highest Possible price of EDIT stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, EDIT can achieve the highest price of $3.59 which is 19.641403742827237 higher than last closing price. This prediction may vary from other time period filters for EDIT stock.

What can be the lowest Possible price of EDIT stock in next 2 weeks?

As per the forecast and algorithmic analysis, EDIT stock price can be as low as $2.94 which is -1.9819255961406472 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for EDIT stock.

Will EDIT stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that EDIT stock will gain8.806666666666674 in the next 2 weeks. This prediction may vary from other time period filters for EDIT stock.

What is EDIT stock last closing price?

Last closing price of EDIT stock was $3.00.

What is EDIT stock price prediction?

EDIT stock price prediction means predicting the future closing prices of EDIT stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of EDIT stock in a certain time period.

How we predict EDIT stock future prices?

If you are searching for EDIT stock forecast, analysis or price prediction, then you might be wondering what Editas Medicine, Inc. (EDIT) will do in the future. Our EDIT price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This EDIT price prediction will likely answer most of your questions.

How frequent we update EDIT stock predictions?

We are updating the forecasts for the EDIT stock on daily basis.

Is using ML forecasting for EDIT stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for EDIT stock same for all the time periods?

No, the prediction for EDIT stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Editas Medicine, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$3.00-9.09%Since 2 Weeks

Predicted Price$3.268.81%For 2 Weeks

Upper Predicted Price$3.5919.64%For 2 Weeks

Lower Predicted Price$2.94-1.98%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of EDIT will rise by +8.81% over the next 2 Weeks and hit $3.26 by Monday, May 18, 2026. In that time frame, EDIT's share price is expected to range between $2.94 and $3.59.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 18, 2026	2.94	3.26	3.59
May 15, 2026	2.93	3.24	3.55
May 14, 2026	2.94	3.24	3.58
May 13, 2026	2.81	3.13	3.48
May 12, 2026	2.88	3.19	3.53
May 11, 2026	2.81	3.13	3.48
May 8, 2026	2.78	3.11	3.42
May 7, 2026	2.77	3.10	3.43
May 6, 2026	2.66	3.00	3.29
May 5, 2026	2.73	3.06	3.38

EDIT shares rose +3.45% in Monday, May 4, 2026's trading session, rising from a previous close of $2.90 to move at $3.00. The stock demonstrated notable intraday movement (see EDIT's key stats for a full breakdown), fluctuating between $2.88 and $3.08, a +6.94% trading range. While recent weeks have seen some volatility, EDIT has managed to secure a -14.04% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 980.05K shares changing hands, 162.08K fewer than the previous session. This amounted to $2.94M in total market activity.

Will EDIT Continue Its Upward Trend?

According to analyst ratings and projections for EDIT, Editas Medicine, Inc. shares are anticipated to increase by +16.42%, potentially reaching $3.59 per share by May 18, 2026. Short-term technical indicators currently suggest a neutral sentiment for EDIT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the EDIT stock forecast, now is a good time to buy EDIT stock because its current trading price is -8.09% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on EDIT covering social and institutional perspectives.

EDIT Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into EDIT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 49.74% to 54.29%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 54.06%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.09%, maintains a neutral outlook for the long term. Insights into EDIT's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Editas Medicine Short-Term Forecasts

EDIT Forecast For Next 5 Days

Our algorithm anticipates Editas Medicine (EDIT) stock could hit $3.13 by May 11, 2026. This represents a +4.39% fall from today's price, following a -5.16% change over the past five days.

EDIT Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Editas Medicine, Inc. (EDIT) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $3.16, which would mean a +5.33% increase from the current price of $3.00. Projections for this period range from a high of $3.76 to a low of $2.59.

EDIT Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Editas Medicine's price over the next three months point to a rise. EDIT stock is expected to peak at $14.92 on Aug 04, 2026 after potentially dipping to $7.99 on May 07, 2026. On average, EDIT is likely to trade around $11.02 in the coming 90 days.

Editas Medicine Stock Forecast 2025

Based on our predictive models, Editas Medicine (EDIT) is expected to trade between $7.60 and $18.57 throughout 2026. This would result in an average price of $13.80, potentially offering investors a +360.00% return from current levels.

Editas Medicine, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Editas Medicine, Inc. (EDIT) is positioned to show a strong performance in May 2026. The price is predicted to move between $7.99 and $10.64, settling at an average of $9.27. This could translate to a +209.00% gain.

June 2026

Based on current market signals, Editas Medicine, Inc. is projected to trend june 2026. We forecast a trading range from $10.18 to $11.09, with a likely average price of $10.64. Investors could expect a potential return of +254.67%.

July 2026

Our predictive algorithms indicate Editas Medicine, Inc. stock may see a shift in July 2026. The expected range spans $10.49–$14.78, with an average target of $12.35. This represents a positive outlook and a possible gain of +311.67%.

August 2026

Analyzing established trends, Editas Medicine, Inc. looks set to move in August 2026. Projections place the stock between $13.42 and $18.04, averaging around $15.81. This suggests a +427.00% gain from current levels.

September 2026

Market indicators suggest Editas Medicine, Inc. could experience notable changes during September 2026. Prices could fluctuate within $12.62 to $18.37, with a midpoint forecast of $17.10. The stock might deliver a +470.00% gain.

October 2026

Forecasting for October 2026, models estimate that Editas Medicine, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $10.68 and $16.34, averaging $14.94. This signals a positive trajectory with potential returns around +398.00%.

November 2026

According to our latest forecast models, Editas Medicine, Inc. (EDIT) is positioned to show a strong performance in November 2026. The price is predicted to move between $9.94 and $18.57, settling at an average of $15.44. This could translate to a +414.67% gain.

December 2026

Based on current market signals, Editas Medicine, Inc. is projected to trend december 2026. We forecast a trading range from $7.60 to $18.12, with a likely average price of $14.41. Investors could expect a potential return of +380.33%.

January 2027

Our predictive algorithms indicate Editas Medicine, Inc. stock may see a shift in January 2027. The expected range spans $5.62–$17.29, with an average target of $13.41. This represents a positive outlook and a possible gain of +347.00%.

February 2027

Analyzing established trends, Editas Medicine, Inc. looks set to move in February 2027. Projections place the stock between $5.25 and $17.68, averaging around $12.65. This suggests a +321.67% gain from current levels.

March 2027

Market indicators suggest Editas Medicine, Inc. could experience notable changes during March 2027. Prices could fluctuate within $4.45 to $17.59, with a midpoint forecast of $12.73. The stock might deliver a +324.33% gain.

April 2027

Forecasting for April 2027, models estimate that Editas Medicine, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $3.80 and $18.34, averaging $12.16. This signals a positive trajectory with potential returns around +305.33%.

May 2027

According to our latest forecast models, Editas Medicine, Inc. (EDIT) is positioned to show a strong performance in May 2027. The price is predicted to move between $3.90 and $18.66, settling at an average of $12.71. This could translate to a +323.67% gain.

EDIT's history of dividends and stock splits also plays a role in long-term investor confidence.